Published in Eur J Pharmacol on November 27, 1984
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Clinical management of benzodiazepine dependence. Br Med J (Clin Res Ed) (1985) 0.86
Neurochemical and metabolic aspects of antidepressants: an overview. J Psychiatry Neurosci (2000) 0.77
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 2.58
Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry (1989) 2.41
The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci (2000) 2.04
Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev (1997) 1.98
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A (1995) 1.91
The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) (1988) 1.63
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther (1990) 1.60
The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci (2000) 1.56
Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A (1997) 1.55
Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci U S A (1984) 1.48
Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther (1989) 1.42
Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci (1999) 1.42
Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. Proc Natl Acad Sci U S A (1981) 1.39
Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity. J Physiol (2003) 1.39
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
An analysis of the negative inotropic action of somatostatin. Br J Pharmacol (1979) 1.37
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol (1992) 1.33
Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A (1995) 1.33
Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci (2001) 1.30
Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem (2000) 1.29
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem (1992) 1.28
A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) (1989) 1.23
Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience (2000) 1.21
Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol (1997) 1.20
Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol (2000) 1.20
Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience (2005) 1.20
[3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience (1997) 1.17
Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience (2003) 1.13
Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res (1999) 1.13
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol (2000) 1.12
Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain. J Comp Neurol (1993) 1.12
Acetylcholine release is elicited in the visual cortex, but not in the prefrontal cortex, by patterned visual stimulation: a dual in vivo microdialysis study with functional correlates in the rat brain. Neuroscience (2005) 1.11
Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Brain Res (1998) 1.10
Interleukin-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev (1995) 1.10
Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol (1998) 1.08
The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem (2000) 1.08
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol (2000) 1.08
Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem (1998) 1.08
A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J Neurosci (1996) 1.07
Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci (1993) 1.07
Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res (1993) 1.07
C-type natriuretic peptide and the guanylyl cyclase receptors in the rat ovary are modulated by the estrous cycle. Biol Reprod (1997) 1.06
Apoptosis in target organs of hypertension. Hypertension (1995) 1.05
Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brain. Peptides (1987) 1.05
An in vivo profile of beta-endorphin release in the arcuate nucleus and nucleus accumbens following exposure to stress or alcohol. Neuroscience (2004) 1.04
Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. Am J Physiol (1997) 1.04
Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway. J Neural Transm Suppl (2000) 1.02
Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Brain Res (1985) 1.01
Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev (2001) 1.01
Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci (1997) 1.00
Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther (1991) 1.00
High resolution radioautographic localization of [125I]FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats. Neuroscience (1991) 0.99
Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5). Can J Physiol Pharmacol (2000) 0.99
Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. J Comp Neurol (1993) 0.98
Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3. Cell Death Differ (1999) 0.98
Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats. Neuroscience (1997) 0.98
Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates. Neuroscience (2002) 0.97
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity. Hypertension (1999) 0.97
Evidence for an endogenous peptide ligand for the phencyclidine receptor. Peptides (1985) 0.97
Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide. Brain Res (1990) 0.97
Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse (1989) 0.97
Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J Pharmacol Exp Ther (1995) 0.97
The stimulatory effects of neurotensin and related peptides in rat stomach strips and guinea-pig atria. Br J Pharmacol (1980) 0.97
Atrial natriuretic factor (ANF) binding sites in brain and related structures. Peptides (1985) 0.96
Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem (1988) 0.96
A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides (1985) 0.96
Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res (1999) 0.96
Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. J Neurosci (1996) 0.95
Characterization and distribution of receptors for the atrial natriuretic peptides in mammalian brain. Proc Natl Acad Sci U S A (1986) 0.95
Comparative laminar distribution of various autoradiographic cholinergic markers in adult rat main olfactory bulb. J Chem Neuroanat (1995) 0.94
Role of the central benzodiazepine receptor system in behavioral habituation to novelty. Behav Neurosci (1989) 0.94
Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc Natl Acad Sci U S A (1991) 0.94
Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res (1989) 0.94
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience (1986) 0.94
Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Neuroscience (1997) 0.94
Ionotropic glutamate receptor subtypes in the aged memory-impaired and unimpaired Long-Evans rat. Neuroscience (1996) 0.94
Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus. Neuroscience (2007) 0.93
Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic Biol Med (1999) 0.93
Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. J Comp Neurol (1996) 0.93
Structural study of the N-terminal segment of neuropeptide tyrosine. J Med Chem (1990) 0.93
Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat (2000) 0.93
Diazepam in high doses is effective in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.93
Mechanisms of the cardiovascular effects of neurotensin. Ann N Y Acad Sci (1982) 0.93
Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res (1989) 0.93
Altered calcitonin gene-related peptide, substance P and enkephalin immunoreactivities and receptor binding sites in the dorsal spinal cord of the polyarthritic rat. Eur J Neurosci (1994) 0.92
Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J Neurosci (1996) 0.92
Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites. J Pharmacol Exp Ther (1995) 0.92
Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol (1999) 0.92
Reactivity to novelty in cognitively-impaired and cognitively-unimpaired aged rats and young rats. Neuroscience (1998) 0.92
Application of in vivo microdialysis to the study of cholinergic systems. Methods (2001) 0.92
Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. Mini Rev Med Chem (2008) 0.92
[(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors. Br J Pharmacol (2000) 0.91
Localization of opiate binding sites in kidney and adrenal gland of the rat. Life Sci (1983) 0.91